|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net earnings (loss) | |||||
| Adjustments to reconcile net earnings (loss) to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Share-based compensation expense | |||||
| Non-cash restructuring charges | |||||
| Non-cash restructuring and impairment charges | |||||
| Amortization of discount on convertible debt and debt issuance costs | |||||
| Amortization of debt issuance costs | |||||
| Loss on disposals of property, plant & equipment | |||||
| Unrealized losses (gains) on foreign currency remeasurements and transactions | |||||
| Loss (earnings) from equity investments | |||||
| Deferred income taxes | |||||
| Gain on sale of business | |||||
| Gain on sale of equity investment | |||||
| Loss on debt extinguishment | |||||
| Increase (decrease) in cash from changes in: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable | |||||
| Contract liabilities | |||||
| Income taxes | |||||
| Accrued compensation and benefits | |||||
| Other operating net assets (liabilities) | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Additions to property, plant & equipment | |||||
| Purchases of businesses, net of cash acquired | |||||
| Purchases of intangible assets | |||||
| Proceeds from sale of equity investment | |||||
| Proceeds from the sale of business, net of fees | |||||
| Purchases of short-term investments | |||||
| Proceeds from sales/maturities of short-term investments | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from borrowing of credit facility | |||||
| Term A Loan | |||||
| Term B Loan | |||||
| Proceeds from issuance of Series B preferred shares | |||||
| Total proceeds from issuance of Series B preferred shares | |||||
| Proceeds from borrowings of revolving credit facilities | |||||
| Total proceeds from borrowings of revolving credit facilities | |||||
| Proceeds from issuance of Senior Notes | |||||
| Proceeds from borrowings of other credit facilities | |||||
| Proceeds from issuance of common shares | |||||
| Payments on existing debt | |||||
| Payments on borrowings under revolving credit facilities | |||||
| Payments on convertible notes | |||||
| Payment of Finisar Notes | |||||
| Debt issuance costs | |||||
| Equity issuance costs | |||||
| Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan | |||||
| Payments in satisfaction of employees’ minimum tax obligations | |||||
| Cash dividends paid | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | |||||
| Cash, Cash Equivalents, and Restricted Cash at End of Period | |||||
| Supplemental Information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-Cash Investing and Financing Activities: | |||||
| Additions to property, plant & equipment included in accounts payable | |||||
| Conversion of Series A and B preferred stock to common stock | |||||
| Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Restricted cash | |||||
| Cash, cash equivalents, and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
| Restricted cash, non-current | |||||
Loading...